Max and Lorayne Cooper Professor for Ophthalmology; Residency Training Director; Uveitis/Ocular Inflammatory Disease Service
Areas of Interest
ocular inflammatory diseases, including uveitis, iritis, and scleritis; role of complement in ocular diseases
Dr. Read's clinical practice and research focuses on uveitis and ocular inflammatory disease. In his research, Dr. Read’s goal is to understand the underlying reasons for health disparities among patients with uveitis. To accomplish this goal, current areas of focus are two fold. First, clinical data from patient care clinics is used to establish patient characteristics that predict worse disease severity and outcomes. Secondly, using an animal model of uveitis, Dr. Read is exploring the effect of melanin on disease severity. Dr. Read has authored or coauthored over 120 papers, book chapters, and abstracts.
Dr. Read received subspecialty training in both uveitis/ocular inflammatory diseases and ophthalmic pathology at the Doheny Eye Institute at the University of Southern California following completion of an ophthalmology residency at the University of Washington in Seattle. After joining the full-time faculty at UAB in 2000, Dr. Read received a Career Development Award from the National Eye Institute at the NIH which facilitated his earning a Ph.D. in immunology with a focus on the role of the complement system on uveitis. Dr. Read’s research has been funded by the NIH, the EyeSight Foundation of Alabama, the International Retinal Research Foundation and The Matthews Foundation. He is the recipient of a Research to Prevent Blindness Physician-Scientist Award, Dr. Read currently serves as chair of both the “Basic and Clinical Science Course” committee for intraocular inflammation and uveitis and the “Practicing Ophthalmologist Curriculum” for uveitis, both the main teaching texts on uveitis published by the American Academy of Ophthalmology. He currently serves as the executive secretary for the American Uveitis Society and is on the board of directors of the Alabama Academy of Ophthalmology, and is on the editorial board of the Journal of Ophthalmic Inflammation and Infection.
Dr. Read is board certified by the American Board of Ophthalmology and has been selected as one of the “Best Doctors in America” yearly since 2005.
Education & Training
Residency in Ophthalmology
University of Washington Seattle
Fellowship, uveitis/ocular inflammatory disease
Doheny Eye Institute, University of Southern California
Callahan Eye Hospital, Suite 601